|
Model Number RSAR-34 |
Device Problem
Incomplete Coaptation (2507)
|
Patient Problems
Atrial Fibrillation (1729); Dyspnea (1816); Headache (1880); Low Blood Pressure/ Hypotension (1914); Tachycardia (2095); Heart Block (4444)
|
Event Date 08/25/2021 |
Event Type
Injury
|
Manufacturer Narrative
|
Further information regarding this event has been requested.The results/method and conclusion codes along with investigation results will be provided in a subsequent submission.
|
|
Event Description
|
It was reported on 23 june 2021, a 34mm sjm rigid saddle ring was implanted.On (b)(6) 2021, the patient presented with intermittent short term supraventricular tachycardia and mitral valve prolapse (mvp) and medication was stopped.On (b)(6) 2021, the patient was discharged.On (b)(6) 2021, the patient presented to the emergency room (er) experiencing palpitations and an electrocardiogram (ecg) was performed and noted atrial fibrillation, with a fast ventricular response and secondary repolarization disorder was reported.The patient received 300mg of amiodarone which resolved the arrhythmia and covered to sinus rhythm.This is most likely due to the implant procedure.The patient was reported to be in stable condition and is now home.(b)(4).
|
|
Manufacturer Narrative
|
An event of intermittent short term supraventricular tachycardia and mitral valve prolapse (mvp) was reported.A more comprehensive assessment could not be performed as the device was not returned for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.Based on the information received, the cause of the reported incident could not be conclusively determined.
|
|
Manufacturer Narrative
|
Correction: b5, d6a.
|
|
Event Description
|
It was reported on (b)(6) 2021, a 34mm sjm rigid saddle ring was implanted in the mitral position.On (b)(6) 2021, the patient presented with intermittent short term supraventricular tachycardia and mitral valve prolapse (mvp) and medication was stopped.The patient was experiencing dyspnea and palpitations due to the mvp.The patient was admitted to the hospital due to the mvp.On (b)(6) 2021, the patient was discharged.On (b)(6) 2021, the patient presented to the emergency room (er) experiencing palpitations and an electrocardiogram (ecg) was performed and noted atrial fibrillation, with a fast ventricular response and secondary repolarization disorder was reported.The patient received 300mg of amiodarone which resolved the arrhythmia and covered to sinus rhythm.This is most likely due to the implant procedure.The patient was reported to be in stable condition and is now home.On (b)(6) 2021, the patient present to the hospital with a headache and low blood pressure.A tee was performed for rule out pericardial fluid.No pericardial fluid was noted.
|
|
Search Alerts/Recalls
|
|
|